SFI
STRO icon

Susquehanna Fundamental Investments’s Sutro Biopharma STRO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,796
Closed -$24.7K – 990
2025
Q1 		$24.7K Sell
3,796
-4,985
-57% -$78.5K ﹤0.01% 1051
2024
Q4 		$162K Buy
+8,781
New +$268K ﹤0.01% 1022
2024
Q2 		$660K Buy
22,537
+9,891
+78% +$391K 0.02% 632
2024
Q1 		$714K Buy
+12,646
New +$559K 0.03% 406
2023
Q4 		– Sell
-7,111
Closed -$247K – 302
2023
Q3 		$247K Sell
7,111
-188
-3% -$8.19K 0.02% 309
2023
Q2 		$339K Hold
7,299
– – 0.01% 498
2023
Q1 		$337K Sell
7,299
-407
-5% -$25.8K 0.01% 764
2022
Q4 		$623K Buy
+7,706
New +$536K 0.01% 798
2022
Q1 		– Sell
-1,799
Closed -$268K – 1684
2021
Q4 		$268K Sell
1,799
-1,925
-52% -$345K 0.01% 1152
2021
Q3 		$703K Sell
3,724
-1,095
-23% -$208K 0.01% 1043
2021
Q2 		$896K Sell
4,819
-276
-5% -$54K 0.02% 894
2021
Q1 		$1.16M Sell
5,095
-1,270
-20% -$301K 0.02% 829
2020
Q4 		$1.38M Buy
6,365
+2,152
+51% +$356K 0.03% 746
2020
Q3 		$423K Buy
+4,213
New +$398K 0.01% 940

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Susquehanna Fundamental Investments's STRO Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 3,796 shares — an estimated $24.7K sold.

Susquehanna Fundamental Investments first reported a position in STRO in Q3 2020 and held it in 14 quarters. The position peaked at $1.38M in Q4 2020. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 3,796 Sutro Biopharma shares in Q2 2025, an estimated $24.7K.
  • Susquehanna Fundamental Investments first reported a position in Sutro Biopharma in Q3 2020 and held it in 14 quarters.
  • Susquehanna Fundamental Investments's Sutro Biopharma position peaked at $1.38M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.